Synapse - Marc Ladanyi

Search Within

Marc Ladanyi

Results (1334)

Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas

Journal Article

Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers

Journal Article

Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Neurofibromatosis type 2-yes-associated protein and transcriptional coactivator with PDZ-binding motif dual immunohistochemistry is a reliable marker for the detection of neurofibromatosis type 2 alterations in diffuse pleural mesothelioma

Journal Article

Li, Y.; Yang, S. R.; Chen, Y. B.; Adusumilli, P. S.; Bialik, A.; Bodd, F. M.; Ladanyi, M.; Lopardo, J.; Offin, M. D.; Rusch, V. W.; more...
Modern Pathology (2023)

Fulltext@MSK | Save

Germline study points to sarcoma pathways: Pathogenic variants related to mitosis and telomere integrity are enriched in sarcoma patients

Editorial

Mandelker, D.; Ladanyi, M.
Science (2023)

Fulltext@MSK | Save

Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study

Journal Article

Abramson, D. H.; Mandelker, D. L.; Brannon, A. R.; Dunkel, I. J.; Benayed, R.; Berger, M. F.; Arcila, M. E.; Ladanyi, M.; Friedman, D. N.; Jayakumaran, G.; more...
PLoS ONE (2023)

Fulltext@MSK | Save

Predicting molecular subtype and survival of rhabdomyosarcoma patients using deep learning of H&E images: A report from the Children's Oncology Group

Journal Article

Milewski, D.; Jung, H.; Brown, G. T.; Liu, Y.; Somerville, B.; Lisle, C.; Ladanyi, M.; Rudzinski, E. R.; Choo-Wosoba, H.; Barkauskas, D. A.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance

Journal Article

Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors

Journal Article

Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma

Journal Article

Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Variability in NTRK gene fusions does not appear to impact response to larotrectinib

Meeting Abstract

Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
Cancer Research (2022)

Fulltext@MSK | Save